Art

J-GLOBAL ID：201302292915023024   Reference number：13A0812523

Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: Rationale and design of the ASsessment of clinical Usefulness in CKD patients with Atorvastatin (ASUCA) trial

脂質異常症と慢性腎臓病を伴った患者の腎機能に対するアトルバスタチンの効果:CKD患者に対するアトルバスタチンの臨床的有用性評価(ASUCA)試験の原理とデザイン

Author (11)： UESHIMA Kenji (Kyoto Univ. Graduate School of Medicine, Kyoto, JPN) ,  KASAHARA Masato (Kyoto Univ. Graduate School of Medicine, Kyoto, JPN) ,  KOYA Daisuke (Kanazawa Medical Univ., Kanazawa, JPN) ,  BABAZONO Tetsuya (Tokyo Women’s Medical Univ. School of Medicine, Tokyo, JPN) ,  SATO Tosiya (Kyoto Univ. School of Public Health, Kyoto, JPN) ,  IMAMOTO Miyuki (Kobe Women’s Junior Coll., Kobe, JPN) ,  YASUNO Shinji (Kyoto Univ. Graduate School of Medicine, Kyoto, JPN) ,  FUJIMOTO Akira (Kyoto Univ. Graduate School of Medicine, Kyoto, JPN) ,  TANAKA Shiro (Kyoto Univ. Hospital, Kyoto, JPN) ,  KIMURA Genjiro (Nagoya City Univ. Graduate School of Medical Sci., Nagoya, JPN) ,  NAKAO Kazuwa (Kyoto Univ. Graduate School of Medicine, Kyoto, JPN)
Material： Clinical and Experimental Nephrology  (Clin Exp Nephrol)
Volume： 17  Issue： 2  Page： 211-217  Publication year： Apr. 2013 
JST Material Number： L3173A  ISSN： 1342-1751  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Thesaurus term： *hyperlipidemia ,...
Semi thesaurus term： renal function ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=13A0812523&from=J-GLOBAL&jstjournalNo=L3173A") }}

JST classification (3)： Treatment for metabolic diseases,nutritional diseases.  (GD05030F) ,  Clinical application of drugs acting on lipid metabolism  (GW13050X) ,  Clinical medicine on urogenital system in general  (GM01030E)

Substance index (2)： Atorvastatin ,  Creatinine

Reference (15)：

• CHHATRIWALLA, AK. Low levels of low-density lipoprotein cholesterol and blood pressure and progression of coronary atherosclerosis. J Am Coll Cardiol. 2009, 53, 1110-1115
• MABUCHI, H. Japan Lipid Intervention Trial : large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia and coronary heart disease : secondary prevention cohort study of the Japan Lipid Intervention Trial (J-LIT). Circ J. 2002, 66, 1096-1100
• EL-ATAT, FA. The relationship between hyperinsulinemia, hypertension and progressive renal disease. J Am Soc Nephrol. 2004, 15, 2816-2827
• RAVID, M. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Intern Med. 1998, 158, 998-1004
• CORESH, J. Prevalence of chronic kidney disease in the United States. JAMA. 2007, 298, 2038-2047

Terms in the title (11)： 脂質異常症 ,  慢性腎臓病 ,  患者 ,  腎機能 ,  アトルバスタチン ,  CKD ,  臨床的有用性 ,  評価 ,  試験 ,  原理 ,  デザイン